Related Experiment Videos

Calcium channel blocking agents in bronchial hyperreactivity

Insights

Calcium channel blockers like nifedipine effectively reduce bronchoconstriction. Nifedipine is more effective than verapamil, impacting airway smooth muscle and potentially mast cells.

Area of Science:

  • Pharmacology
  • Respiratory Medicine
  • Physiology

Background:

  • Bronchoconstriction is a key feature of various respiratory diseases.
  • Calcium ions play a crucial role in the pathways leading to bronchoconstriction.
  • Calcium channel blockers are investigated for their potential to mitigate airway smooth muscle contraction.

Purpose of the Study:

  • To evaluate the efficacy of nifedipine and verapamil in blunting bronchoconstriction.
  • To investigate the sites of action of these calcium channel blockers within the airways.
  • To compare the effectiveness of nifedipine versus verapamil in preclinical and clinical models.

Main Methods:

  • Conducted clinical and animal bronchial challenge experiments.
  • Administered methacholine and histamine to induce bronchoconstriction.
  • Assessed the impact of exercise and cold air hyperpnea on airway caliber.
  • Measured the blunting effects of nifedipine and verapamil on airway responses.

Main Results:

  • Nifedipine demonstrated greater efficacy in blunting bronchoconstriction compared to verapamil.
  • Nifedipine attenuated airway responses to methacholine and histamine inhalation.
  • Nifedipine reduced bronchoconstriction induced by exercise and cold air hyperpnea.
  • The precise mechanism remains complex due to the widespread role of calcium ions.

Conclusions:

  • Nifedipine is an effective agent for blunting various forms of bronchoconstriction.
  • Nifedipine likely acts directly on airway wall smooth muscle.
  • Nifedipine may also influence mast cell mediator release, contributing to its efficacy.

Related Concept Videos